Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVX502 Influenza Vaccine Trial
NCT00440362Phase 2Completed
- Sponsor
- AlphaVax, Inc.
- Start
- Apr 2007
- Primary completion
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AVX502 in influenza, sponsored by AlphaVax, Inc.. Started Apr 2007; status: completed.
02
Drugs
AVX502
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00440362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440362.